Equities

Richter Gedeon Vegyeszeti Gyar Nyrt

Richter Gedeon Vegyeszeti Gyar Nyrt

Actions
  • Price (USD)24.85
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Apr 03 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
RICHTER:BUD since
announced
Transaction
value
Richter-Helm Biologics GmbH & Co KGAnnounced06 Mar 202406 Mar 2024Announced-3.13%44.07m
Richter-Helm Biotec GmbH & Co. KGAnnounced06 Mar 202406 Mar 2024Announced-3.13%77.94m
Giskit MD BVAnnounced20 Jul 202320 Jul 2023Announced5.68%33.59m
Data delayed at least 15 minutes, as of Jun 14 2024 16:05 BST.

Institutional shareholders

0.12%Per cent of shares held by top holders
HolderShares% Held
Fiera Capital (UK) Ltd.as of 30 Jun 202396.41k0.05%
Vector Asset Management S.A.as of 31 Dec 202360.00k0.03%
M�tropole Gestion SAas of 31 Dec 202121.70k0.01%
State Street Global Advisors France SAas of 31 Dec 202219.21k0.01%
Franklin Templeton Institutional LLCas of 31 Mar 202410.66k0.01%
Dimensional Fund Advisors Ltd.as of 31 Dec 20218.64k0.01%
HSBC Global Asset Management (Hong Kong) Ltd.as of 31 Jul 20225.29k0.00%
First Trust Advisors LPas of 31 Mar 20242.23k0.00%
BlackRock Advisors (UK) Ltd.as of 31 Jul 20231.12k0.00%
More ▼
Data from 31 Dec 2023 - 13 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.